This week on Contemporary OB/GYN®: Jan. 17 to Jan. 21
Here's what's coming to Contemporary OB/GYN® this week.
The need for a universal endometriosis classification
A literature search revealed there is no international agreement on how to characterize or classify endometriosis.
Read now
Treating recurrent vulvovaginal candidiasis with honey
Because the mechanism of action of medical-grade honey (MGH) is based on enhancing wound healing and exerting strong broad-spectrum antimicrobial activity, MGH may also help to treat recurrent vulvovaginal candidiasis (RVVC), according to a review in the Journal of Fungi.
Microbial interplay of recurrent vulvovaginal candidiasis pathobiology
A clinical study has confirmed that the pathophysiology of recurrent vulvovaginal candidiasis (RVVC) relies primarily on Candida albicans (C. albicans)-specific attributes like hyphal morphogenesis, biofilm formation and pathogenesis that differentiate it from other prominent non-albicans C. (NAC) species.
Patient perspectives on vulvovaginal candidiasis
Among women with vulvovaginal candidiasis (VVC) or recurrent VVC (RVVC), the three 3 most common signs and /symptoms are itching (91.2%), burning (68.3%), and redness (58.1%), according to an online patient survey in BMC Womens Health.
Major congenital malformations not linked to first trimester tetracycline use
November 20th 2024A large population-based study found that first-trimester tetracycline exposure does not elevate the risk of major congenital malformations, though specific risks for nervous system and eye anomalies warrant further research.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More
